Autoinjectors Market - By Type (Disposable, Reusable), By Route of Administration (Subcutaneous, Intramuscular), By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Diabetes, Oncology, Asthma, Migraine, Hormone Therapy), End-use & Global Forecast, 2032
Published Date: August - 2024 | Publisher: MIR | No of Pages: 240 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationAutoinjectors Market - By Type (Disposable, Reusable), By Route of Administration (Subcutaneous, Intramuscular), By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Diabetes, Oncology, Asthma, Migraine, Hormone Therapy), End-use & Global Forecast, 2032
Autoinjectors Market Size
Autoinjectors Market size was valued at over USD 55 billion in 2022 and is projected to register over 13% CAGR between 2023 and 2032. Rising prevalence of chronic diseases, growing demand for self-injection devices, and advancements in technology are some of the factors contributing to global market growth.
More and more people are living with chronic diseases like diabetes, rheumatoid arthritis, and multiple sclerosis. This means they need a lot of injections, and autoinjectors are a great way to give these medications safely and effectively. For example, there are about 537 million people around the world with diabetes. That's a ton of people! And it's only going to go up in the future. In fact, about half of the people with diabetes don't even know they have it. Most of these people live in countries that don't have a lot of money. And diabetes is a big problem there. It causes over 1.5 million deaths a year. That's why it's so important for people to take care of themselves and try to prevent diabetes and other chronic diseases. And autoinjectors can help people do that by making it easier to get the medications they need.
An autoinjector is a medical device used for the administration of a specific dose of a medication, typically via injection. It is designed to be easy to use by the patient or caregiver and typically consists of a pre-filled syringe, a needle, and a spring-loaded mechanism that delivers the medication quickly and easily with the press of a button. Autoinjectors are commonly used to treat conditions such as allergies, arthritis, and multiple sclerosis, among others. They are often used in emergency situations where rapid administration of medication is necessary, and they can help reduce the risk of accidental needle stick injuries.
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Autoinjectors Market Size in 2022 | USD 55 Billion |
| Forecast Period | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR | 13.1% |
| 2032 Value Projection | USD 186 Billion |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 175 |
| Tables, Charts & Figures | 230 |
| Segments covered | Type, Route of Administration, Therapy, End-use, and Region |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
Autoinjectors Market Trends
You may find generic autoinjectors in the market, but their availability can differ depending on where you live and what medication you need. Sometimes, the company that created the original autoinjector has the exclusive right to make and sell it for a while, which is called a patent. When the patent runs out, other companies may be able to make and sell generic versions of the autoinjector. In some countries, government agencies like the FDA in the US or the EMA in Europe need to make sure generic autoinjectors are safe and effective before they can be sold. This can take some time, and they may need to do clinical trials or other tests. Also, big companies in this industry are working hard to come up with new types of autoinjectors and bring them to market, which is expected to help the industry grow in the coming years.
Autoinjectors Market Analysis
The autoinjector market is like a big puzzle with two main piecesdisposable and reusable autoinjectors. In 2022, the disposable autoinjectors piece was worth a whopping 37 billion dollars! Why are disposable autoinjectors so popular? Well, they're like tiny helpers for people with chronic illnesses. They make it easier for patients to give themselves the right amount of medicine at the right time. Plus, they're always improving and getting better at treating diseases. More and more patients are choosing disposable autoinjectors because they can manage their own health better. They're also easier to find nowadays as more companies are making new and innovative autoinjector technology. So, the disposable autoinjector puzzle piece is definitely growing in popularity!
Autoinjectors market is bifurcated based on the route of administration including subcutaneous and intramuscular. There has been a rising trend in patient preference towards self-administration of medication through autoinjectors in recent years. Autoinjectors provide patients with a more convenient way to self-administer their medication, which can be particularly beneficial for patients with chronic conditions that require frequent injections. Self-administration through autoinjectors gives patients more control over their treatment, allowing them to administer medication at a time and place that are most convenient to them. Such benefits offered by the autoinjectors will fuel the segment demand.
The market for autoinjectors, devices that help people easily and accurately inject themselves with medications, is split into different categories based on the condition they're used to treat. One of these categories is rheumatoid arthritis (RA), a common condition that causes joint pain and inflammation. In 2022, RA accounted for about 25% of the autoinjector market, and it's expected to remain a major player in the future. RA affects about 1% of people worldwide, especially women. It's a long-term condition where the body's immune system mistakenly attacks its own joints. To treat RA, patients often need to take medications called disease-modifying antirheumatic drugs (DMARDs) by injection. Autoinjectors make it easier for RA patients to give themselves these injections. They're convenient, efficient, and help ensure the medication is taken correctly.
When it comes to using autoinjectors, there are different places where they are being used, like hospitals and clinics, as well as at home. The part about home use is predicted to grow really fast over the next few years, at a rate of 13.4% each year. That's because more and more people are getting healthcare services at home, and autoinjectors are becoming a great way to help with that. These autoinjectors can be used to give different kinds of medicines, such as drugs for rheumatoid arthritis, biological therapies, and even vaccines. As healthcare becomes more advanced and easier to use, the need for autoinjectors in home settings will keep growing. This is because autoinjectors make it easier for patients to give themselves their own medicines at home, which means less work for hospitals and better outcomes for patients.
The autoinjector market in North America is booming, reaching a whopping $25.5 billion in 2022. And it's only going to keep growing in the years to come. Why the surge? A few things are driving this trend. First, more and more people can afford autoinjectors. Second, new and improved ways to treat chronic diseases are being developed all the time. Third, North Americans are spending more and more on healthcare. But that's not all. Big companies with lots of experience in the autoinjector market are playing a big role, too. They're getting new products approved and launching them, especially in the United States. This is making the market even more competitive and exciting.
Autoinjectors Market Share
Some of the notable key industry players operating in the autoinjectors market include
- AbbVie Inc.
- Mylan
- GlaxoSmithKline Plc
- Ypsomed
- Amgen
- Becton
- Dickinson and company
- Eli Lilly and Company
- Johnson & Johnson
- Teva pharmaceuticals
- Antares Pharma
These market participants are implementing various growth strategies such as collaborations, partnerships, acquisitions & mergers, and new type development and launches to strengthen type offerings as well as gain a competitive edge over others.
Autoinjectors Industry News
- In October 2022, Ypsomed launched a new autoinjector platform for liquid pharmaceuticals with capacities between 1.5 mL and 5.5 mL. Such product launches and advancements will boost the market growth.
Impact of COVID-19 Pandemic
COVID-19 outbreak has disrupted numerous healthcare activities, the autoinjector market continues to witness substantial revenue growth. The growing incidence rate of several respiratory complications among COVID-19 patients has further propelled market demand. Autoinjectors are self-administration drug devices, and these devices include a variety of drugs for the treatment of diseases such as rheumatoid arthritis, diabetes, and others. Further, autoinjectors help patients administer a routine dose of medication, which became very popular during the COVID-19 pandemic when healthcare facilities were flooded with COVID patients.
Autoinjectors market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments
Click here to Buy Section of this Report
By Type
- Disposable
- Reusable
By Route of Administration
- Subcutaneous
- Intramuscular
By Therapy
- Rheumatoid arthritis
- Multiple sclerosis
- Anaphylaxis
- Diabetes
- Oncology
- Asthma
- Migraine
- Hormone therapy
- Others
By End-use
- Hospital & clinics
- Homecare settings
- Others
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Asia Pacific
- China
- India
- Japan
- Australia
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- Saudi Arabia
- South Africa
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy